We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$31.1M
Cap. Flow
+$160M
Cap. Flow %
7.34%
Top 10 Hldgs %
25.32%
Holding
187
New
40
Increased
44
Reduced
62
Closed
37

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$42.5M
2
ACHC icon
Acadia Healthcare
ACHC
+$38.6M
3
CNXC icon
Concentrix
CNXC
+$36.4M
4
VTRS icon
Viatris
VTRS
+$33.1M
5
MTB icon
M&T Bank
MTB
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Healthcare 19.11%
3 Consumer Discretionary 12.35%
4 Industrials 11.07%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNTX icon
126
Gentex
GNTX
$5.03B
$2.38M 0.11%
+108,966
New +$2.53M
VNO icon
127
Vornado Realty Trust
VNO
$7.27B
$2.37M 0.11%
+91,102
New +$2.7M
QS icon
128
QuantumScape Corp
QS
$3.53B
$2.31M 0.11%
+362,355
New +$3.01M
RGP icon
129
Resources Connection
RGP
$145M
$2.27M 0.1%
607,815
-30,975
-5% -$127K
JILL icon
130
J. Jill
JILL
$297M
$2.23M 0.1%
194,318
-8,909
-4% -$142K
HURC icon
131
Hurco Companies Inc
HURC
$148M
$1.72M 0.08%
116,728
-7,847
-6% -$129K
TBI
132
Trueblue
TBI
$318M
$1.6M 0.07%
409,436
-32,789
-7% -$146K
OPRX icon
133
OptimizeRx
OPRX
$146M
$1.44M 0.07%
+229,370
New +$2.13M
COTY icon
134
Coty
COTY
$2.41B
$1.44M 0.07%
+714,212
New +$1.92M
UFI icon
135
UNIFI
UFI
$140M
$1.43M 0.07%
400,847
-25,434
-6% -$98K
HLF icon
136
Herbalife
HLF
$1.3B
$1.32M 0.06%
89,773
-678,258
-88% -$11.1M
KLC
137
KinderCare Learning Companies
KLC
$295M
$1.28M 0.06%
+583,486
New +$2.2M
QDEL icon
138
QuidelOrtho
QDEL
$1.02B
$1.25M 0.06%
+76,267
New +$1.87M
JACK icon
139
Jack in the Box
JACK
$316M
$1.22M 0.06%
125,915
-442,164
-78% -$7.82M
ALIT icon
140
Alight
ALIT
$382M
$1.18M 0.05%
101,143
-5,894
-6% -$140K
RMAX icon
141
RE/MAX Holdings
RMAX
$1.13M 0.05%
195,990
-10,983
-5% -$76K
AVD icon
142
American Vanguard Corp
AVD
$65.2M
$1.04M 0.05%
416,840
-26,457
-6% -$113K
SNBR
143
DELISTED
Sleep Number
SNBR
$808K 0.04%
449,934
-33,916
-7% -$255K
EAF icon
144
GrafTech
EAF
$182M
$673K 0.03%
99,312
-6,368
-6% -$67.3K
MDY icon
145
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$492K 0.02%
797
LEXX icon
146
Lexaria Bioscience
LEXX
$18.2M
$345K 0.02%
29,487
-1,907
-6% -$20.8K
PRPL icon
147
Purple Innovation
PRPL
$20.6M
$331K 0.02%
20,000
-5,026
-20% -$87.9K
TLT icon
148
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$47B
$303K 0.01%
3,500
ASHR icon
149
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
$241K 0.01%
7,388
CALF icon
150
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.92B
$216K 0.01%
4,822

Similar funds

Invenomic Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Invenomic Capital Management held 187 positions worth $2.18B, up 1.4% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $160M of net new capital in Q1 2026, opening 40 new positions and adding to 44 existing holdings. Its largest new stake was Workday: 559,955 shares worth $72.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Acadia Healthcare, an estimated $38.6M trimmed.

  • Invenomic Capital Management's largest Q1 2026 buy was Workday: 559,955 shares worth $72.7M.
  • Invenomic Capital Management added most to Fidelity National Information Services in Q1 2026, an estimated $41.7M increase.
  • Invenomic Capital Management's biggest Q1 2026 reduction was Acadia Healthcare, cutting an estimated $38.6M.
  • Invenomic Capital Management fully exited Equinox Gold in Q1 2026, selling an estimated $42.5M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.18B portfolio in Q1 2026.
  • Invenomic Capital Management opened 40 new positions and closed 37 in Q1 2026.
  • Invenomic Capital Management's portfolio value rose 1.4% quarter-over-quarter to $2.18B.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.